{"id":33214,"date":"2020-10-06T09:39:31","date_gmt":"2020-10-06T09:39:31","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=31339"},"modified":"2020-12-07T16:43:08","modified_gmt":"2020-12-07T16:43:08","slug":"escrs-2020-elza-researcher-wins-award-for-pack-cxl-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/escrs-2020-elza-researcher-wins-award-for-pack-cxl-clinical-trial\/","title":{"rendered":"ESCRS 2020: Investigador do ELZA ganha pr\u00e9mio para ensaio cl\u00ednico PACK-CXL"},"content":{"rendered":"

ESCRS 2020<\/strong><\/p>\n

Called a \u201csilent epidemic\u201d by the World Health Organization, bacterial and fungal corneal infections are one of the leading causes of blindness in the world. This isn\u2019t conjunctivitis, which is relatively harmless. This is corneal ulcers, which can cause blindness as quickly as 24 hours. However, the world is running out of antibiotics and antifungal drugs. Alternatives to these drugs are needed \u2013 urgently.<\/p>\n

Against this background, a groundbreaking treatment called PACK-CXL which requires only vitamin B2 and UV-A light, called \u201cPACK-CXL\u201d has been developed. It can kill bacteria and fungi without requiring antimicrobial drugs to do so.<\/p>\n

And so, at this year\u2019s annual meeting of the European Society for Cataract and Refractive Surgery<\/a> (ESCRS), held online from 2\u20134 October 2020, a poster, presented by Dr. Emilio Torres-Netto, entitled “Corneal cross-linking for treating infectious keratitis: final results of the prospective randomized controlled multicentre trial” took first place in the Refractive Surgery category. The phase III trial<\/a> results showed that corneal ulcers can be treated just as effectively with PACK-CXL as with the latest antibiotics, something that will soon become increasingly important.<\/p>\n

The competition was strong: the best work from surgeons and researchers from over 120 countries competed for the best poster prize, and Dr. Torres-Netto, who works as part of the research group of Prof. Farhad Hafezi from the ELZA Institute Dietikon (www.elza-institute.com<\/a>) said that he was \u201chonoured and humbled\u201d to win the Best Poster prize for the second year in a row.<\/p>\n

 <\/p>\n

[foogallery id=”31346″]<\/p>\n

Dr. Torres-Netto previously won the Best Poster prize at the ESCRS Winter Meeting 2020 held in Marrakech, and the last year’s ESCRS Best Poster Prize at the 2019 ESCRS Annual Meeting held in Paris, France. The topic he won these poster prizes for previously was Stromal bed smoothness after excimer laser surface ablation as a key element for the expression of inflammatory genes<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Assim, na reuni\u00e3o anual deste ano da Sociedade Europeia de Catarata e Cirurgia Refractiva (ESCRS 2020), que decorreu online de 2 a 4 de outubro de 2020, um poster, apresentado pelo Dr. Emilio Torres-Netto, intitulado \"Corneal cross-linking for treating infectious keratitis: final results of the prospective randomized controlled multicentre trial\" ficou em primeiro lugar na categoria de Cirurgia Refractiva. Os resultados do ensaio de fase III demonstraram que as \u00falceras da c\u00f3rnea podem ser tratadas de forma t\u00e3o eficaz com o PACK-CXL como com os antibi\u00f3ticos mais recentes, algo que em breve se tornar\u00e1 cada vez mais importante.<\/p>","protected":false},"author":4,"featured_media":34044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[203,243,447,97,467],"tags":[452,125,105,116,106,104],"class_list":["post-33214","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-awards","category-emilio-torres","category-general","category-podium-power","category-top-10","tag-clinical-trial","tag-cornea","tag-corneal-infection","tag-corneal-ulcer","tag-keratitis","tag-pack-cxl"],"acf":[],"yoast_head":"\nESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial<\/title>\n<meta name=\"description\" content=\"ESCRS 2020: Emilio Torres-Netto of the ELZA Institute wins the Best Poster prize for his PACK-CXL clinical trial presentation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial\" \/>\n<meta property=\"og:description\" content=\"ESCRS 2020: Emilio Torres-Netto of the ELZA Institute wins the Best Poster prize for his PACK-CXL clinical trial presentation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-06T09:39:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-07T16:43:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1066\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial\",\"datePublished\":\"2020-10-06T09:39:31+00:00\",\"dateModified\":\"2020-12-07T16:43:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\"},\"wordCount\":317,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png\",\"keywords\":[\"clinical trial\",\"Cornea\",\"Corneal infection\",\"Corneal ulcer\",\"Keratitis\",\"PACK-CXL\"],\"articleSection\":[\"Awards\",\"Emilio Torres\",\"General\",\"Podium Power\",\"Top 10\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\",\"url\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\",\"name\":\"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png\",\"datePublished\":\"2020-10-06T09:39:31+00:00\",\"dateModified\":\"2020-12-07T16:43:08+00:00\",\"description\":\"ESCRS 2020: Emilio Torres-Netto of the ELZA Institute wins the Best Poster prize for his PACK-CXL clinical trial presentation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png\",\"width\":1066,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emilio Torres\",\"item\":\"https:\/\/www.elza-institute.com\/de-ch\/emilio-torres\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ESCRS 2020: Investigador do ELZA ganha pr\u00e9mio para ensaio cl\u00ednico PACK-CXL","description":"ESCRS 2020: Emilio Torres-Netto do Instituto ELZA ganha o pr\u00e9mio de Melhor Poster pela sua apresenta\u00e7\u00e3o do ensaio cl\u00ednico PACK-CXL.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/","og_locale":"pt_PT","og_type":"article","og_title":"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial","og_description":"ESCRS 2020: Emilio Torres-Netto of the ELZA Institute wins the Best Poster prize for his PACK-CXL clinical trial presentation.","og_url":"https:\/\/www.elza-institute.com\/pt\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2020-10-06T09:39:31+00:00","article_modified_time":"2020-12-07T16:43:08+00:00","og_image":[{"width":1066,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png","type":"image\/png"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial","datePublished":"2020-10-06T09:39:31+00:00","dateModified":"2020-12-07T16:43:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/"},"wordCount":317,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png","keywords":["clinical trial","Cornea","Corneal infection","Corneal ulcer","Keratitis","PACK-CXL"],"articleSection":["Awards","Emilio Torres","General","Podium Power","Top 10"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/","url":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/","name":"ESCRS 2020: Investigador do ELZA ganha pr\u00e9mio para ensaio cl\u00ednico PACK-CXL","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png","datePublished":"2020-10-06T09:39:31+00:00","dateModified":"2020-12-07T16:43:08+00:00","description":"ESCRS 2020: Emilio Torres-Netto do Instituto ELZA ganha o pr\u00e9mio de Melhor Poster pela sua apresenta\u00e7\u00e3o do ensaio cl\u00ednico PACK-CXL.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2020\/10\/Emilio-Torres-Netto-Best-Poster-Prize-ESCRS-2020-Refractive-1.png","width":1066,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/de-ch\/zurcher-forscher-prasentieren-neuartige-alternative-zu-antibiotika-in-der-augenheilkunde\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Emilio Torres","item":"https:\/\/www.elza-institute.com\/de-ch\/emilio-torres\/"},{"@type":"ListItem","position":3,"name":"ESCRS 2020: ELZA researcher wins award for PACK-CXL clinical trial"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/33214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=33214"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/33214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/34044"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=33214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=33214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=33214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}